A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
Condition(s):Diabetic Macular EdemaLast Updated:December 17, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Diabetic Macular EdemaLast Updated:December 17, 2014Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:February 9, 2024Recruiting
Condition(s):PAD – Peripheral Arterial Disease; PVD- Peripheral Vascular DiseaseLast Updated:June 1, 2023Terminated
Condition(s):Peripheral Arterial DiseaseLast Updated:February 13, 2012Completed
Condition(s):Provoked VestibulodyniaLast Updated:May 2, 2017Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:June 8, 2023Recruiting
Condition(s):Peripheral Artery Disease; Polyvascular DiseaseLast Updated:January 30, 2024Not yet recruiting
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:February 28, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:February 28, 2024Active, not recruiting
Condition(s):Peripheral Arterial DiseaseLast Updated:January 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.